+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antimicrobial Hydrogel Dressings Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • PDF Icon

    Report

  • 59 Pages
  • December 2022
  • Region: Global
  • GlobalData
  • ID: 5714612
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's Medical Devices sector report, “Antimicrobial Hydrogel Dressings Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Antimicrobial Hydrogel Dressings pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

These are hydrogel dressings impregnated with an agent that inhibits microbial growth.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Antimicrobial Hydrogel Dressings under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Antimicrobial Hydrogel Dressings and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Antimicrobial Hydrogel Dressings under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Antimicrobial Hydrogel Dressings Overview

3 Products under Development
3.1 Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
3.2 Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
3.3 Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
3.4 Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
3.5 Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials

4 Antimicrobial Hydrogel Dressings - Pipeline Products under Development by Companies
4.1 Antimicrobial Hydrogel Dressings Companies - Pipeline Products by Stage of Development
4.2 Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development

5 Antimicrobial Hydrogel Dressings Companies and Product Overview
5.1 CelaCare Technologies LLC Company Overview
5.2 Edixomed Ltd Company Overview
5.3 Gel4Med Inc Company Overview
5.4 In2cure AB Company Overview
5.5 Institute of Nano Science and Technology Company Overview
5.6 Kane Biotech Inc Company Overview
5.7 Novyx Technologies LLC Company Overview
5.8 O2 Regentech LLC Company Overview
5.9 Plurogen Therapeutics Inc Company Overview
5.10 Quick-Med Technologies Inc Company Overview
5.11 Smith & Nephew Plc Company Overview
5.12 Syracuse University Company Overview

6 Antimicrobial Hydrogel Dressings- Recent Developments
6.1 Sep 28, 2022: Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto
6.2 Sep 26, 2022: Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting
6.3 Aug 29, 2022: Covalon Announces Third Quarter Fiscal 2022 Results
6.4 Aug 01, 2022: Advanced Medical Solutions Group Announce Directorate Change
6.5 Jul 13, 2022: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
6.6 Jun 08, 2022: Advanced Medical Solutions Grp Annual General Meeting
6.7 Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update
6.8 Mar 31, 2022: Smith & Nephew announces Directorate Change
6.9 Mar 07, 2022: Smith & Nephew Announces Notice of Annual General Meeting
6.10 Mar 07, 2022: Smith & Nephew Notice of 85th Annual General Meeting
6.11 Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer
6.12 Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer

List of Tables
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
  • Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials
  • Antimicrobial Hydrogel Dressings Companies - Pipeline Products by Stage of Development
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
  • CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • OTC Antimicrobial Gel - Product Status
  • OTC Antimicrobial Gel - Product Description
  • Prescription Gel 1 - Product Status
  • Prescription Gel 1 - Product Description
  • Prescription Gel 2 - Product Status
  • Prescription Gel 2 - Product Description
  • Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • EDX110 - Burns - Product Status
  • EDX110 - Burns - Product Description
  • EDX110 - Cystic Fibrosis - Product Status
  • EDX110 - Cystic Fibrosis - Product Description
  • EDX110 - Diabetic Foot Ulcer - Product Status
  • EDX110 - Diabetic Foot Ulcer - Product Description
  • EDX110 - Pressure Ulcers - Product Status
  • EDX110 - Pressure Ulcers - Product Description
  • EDX110 - Septic Shock - Product Status
  • EDX110 - Septic Shock - Product Description
  • EDX110 - Surgical Wounds - Product Status
  • EDX110 - Surgical Wounds - Product Description
  • EDX110 - Venous Leg Ulcers - Product Status
  • EDX110 - Venous Leg Ulcers - Product Description
  • Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview
  • G4db - Product Status
  • G4db - Product Description
  • G4I - Product Status
  • G4I - Product Description
  • In2cure AB Pipeline Products & Ongoing Clinical Trials Overview
  • TCP-25 - Product Status
  • TCP-25 - Product Description
  • In2cure AB - Ongoing Clinical Trials Overview
  • TCP-25 - A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male and Female Volunteers to Investigate the Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds
  • Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Smart Injectable Hydrogel - Product Status
  • Smart Injectable Hydrogel - Product Description
  • Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Coactiv+ Antimicrobial Hydrogel - Product Status
  • Coactiv+ Antimicrobial Hydrogel - Product Description
  • Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Hydrogel Wound Dressing - Product Status
  • Hydrogel Wound Dressing - Product Description
  • O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview
  • OXAID - Product Status
  • OXAID - Product Description
  • Plurogen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • PluroGel PNN - Product Status
  • PluroGel PNN - Product Description
  • Plurogen Therapeutics Inc - Ongoing Clinical Trials Overview
  • PluroGel PNN - A Between Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries
  • PluroGel PNN - A Within Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries
  • Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Nimbus Hydrogel - Product Status
  • Nimbus Hydrogel - Product Description
  • Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Wound Dressing - Product Status
  • Wound Dressing - Product Description
  • Syracuse University Pipeline Products & Ongoing Clinical Trials Overview
  • Antimicrobial Hydrogel Web - Product Status
  • Antimicrobial Hydrogel Web - Product Description
  • Shape Memory Polymer Hydrogel - Product Status
  • Shape Memory Polymer Hydrogel - Product Description
  • Glossary
List of Figures
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
  • Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
  • Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • CelaCare Technologies LLC
  • Edixomed Ltd
  • Gel4Med Inc
  • In2cure AB
  • Institute of Nano Science and Technology
  • Kane Biotech Inc
  • Novyx Technologies LLC
  • O2 Regentech LLC
  • Plurogen Therapeutics Inc
  • Quick-Med Technologies Inc
  • Smith & Nephew Plc
  • Syracuse University